A new model of brain metabolism – the most complex ever generated –shows how altering key chemicals could restore aged cells ...

SOUTH SAN FRANCISCO, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Corvus or the Company) (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a ...

The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced ...

More details about the programs for the AACR Annual Meeting 2025 are available online at AACR Annual Meeting 2025 | Meetings ...

Phase 3 4WARD trial in chronic neutropenia now activated at ~90% of targeted trial sites; full enrollment expected in 3Q or 4Q 2025; top-line ...

New study results presented at the European Lung Cancer Congress (ELCC) 2025, 26 to 29 March, demonstrate the role of AstraZeneca’s Tagrisso (osimertinib), as monotherapy and as the backbone for novel ...

Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, announced today multiple oral and poster presentations at the ...

Agreement/Incoming OrdersEckert & Ziegler to Supply Actinium Pharmaceuticals with Ac-225 for Comprehensive Development Activities 25.03.2025 / 09:30 CET/CESTThe issuer is solely responsible for the ...

Cannabis is packed with powerful compounds beyond THC and CBD—discover 10 key cannabinoids and how they impact your ...

Aging involves lots of changes throughout the body, but few organs broadcast the process quite as publicly as the skin. Along ...

Past studies have shown that the human sweet taste receptor conveys sweet perception in the mouth and may help regulate ...

Professor Sun Jinpeng's team at Shandong University and collaborators published a research paper titled "Metabolic signaling of ceramides through the FPR2 receptor inhibits adipocyte thermogenesis" in ...